AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,050 | -47.5% | 8,185 | -46.0% | 0.01% | -40.0% |
| Q2 2023 | $1,089,398 | +148.7% | 15,160 | +113.5% | 0.02% | +114.3% |
| Q1 2023 | $437,990 | -11.8% | 7,101 | +10.2% | 0.01% | -12.5% |
| Q4 2022 | $496,794 | +8.0% | 6,441 | -37.5% | 0.01% | 0.0% |
| Q3 2022 | $460,000 | +23.0% | 10,310 | +5.7% | 0.01% | +33.3% |
| Q2 2022 | $374,000 | -7.4% | 9,754 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $404,000 | – | 9,754 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |